How to Find Investors for a Healthtech Startup: Stage Mix, States and Fund Sizes
To find investors for a healthtech and digital health startup, start from our list of 1,207 healthtech and digital health investors and narrow it by stage, place and fund size. Seed is the stage they name most (800 of the 1,043 with a stage on file), ahead of pre-seed. About three fifths are in the US, where California leads with 240. The median fund on file from SEC Form D is $60M, above the $50M for every investor we hold with such a figure.
By type, the 1,207 are 977 VC firms, 51 fund managers, 48 angel networks, 36 government or university funds and 32 corporate venture arms, with 63 of other types. The tags these investors most often carry beside healthtech and digital health are AI (651), SaaS and B2B software (640) and medtech and medical devices (433).
What do healthtech and digital health investors look for?
A health technology pitch is read for who pays. Patients, employers, insurers and hospitals each buy differently, and an investor wants to see the route to payment, the clinical evidence behind the product and the rules it has to meet.
- Who pays, and how? Self-pay, an employer contract, insurance reimbursement and a hospital budget are four different sales motions.
- What clinical evidence do you have? A study with a named clinical partner, even a small one, changes how the claim is read.
- Which rules apply to you? Patient data rules reach many health products, and one that diagnoses or treats may need clearance as a medical device.
Which stage do healthtech and digital health investors back?
Among the 1,043 of the 1,207 with a stage on file (a firm can state several), seed comes first with 800 (77%), then pre-seed (408), Series A (401), growth (316) and Series B (160). Set against every investor we hold, the group leans toward Series A: 38% name it here and 34% overall. With about three quarters naming seed, a seed round has the widest field on this list.
| Stage (our research) | Healthtech investors | Share of the 1,043 with a stage on file | Share of all 1,207 on the list | Same share, all investors with a stage | Difference in points |
|---|---|---|---|---|---|
| Pre-seed healthtech investors | 408 | 39% | 34% | 39% | 0 |
| Seed healthtech investors | 800 | 77% | 66% | 75% | +2 |
| Series A healthtech investors | 401 | 38% | 33% | 34% | +4 |
| Series B healthtech investors | 160 | 15% | 13% | 14% | +1 |
| Growth-stage healthtech investors | 316 | 30% | 26% | 28% | +2 |
Where are healthtech and digital health investors based?
About three fifths of the list is American: 720 of the 1,207 are in the US, 194 in the UK and 291 in the rest of Europe. Among the 707 US investors with a state on file, California holds about a third (240), in line with its 36% share of all US investors we hold. New York is a distant second with 100, then Massachusetts (58) and Texas (42). Massachusetts stands out: it holds 8% of this group and 6% of all US investors.
| State | Healthtech investors | Share of the 707 with a state on file | Share of all US investors | Difference in points |
|---|---|---|---|---|
| California | 240 | 34% | 36% | -2 |
| New York | 100 | 14% | 15% | -1 |
| Massachusetts | 58 | 8% | 6% | +2 |
| Texas | 42 | 6% | 6% | 0 |
| Florida | 37 | 5% | 6% | -1 |
| Illinois | 25 | 4% | 3% | +1 |
| Connecticut | 16 | 2% | 2% | 0 |
| Pennsylvania | 16 | 2% | 1% | +1 |
By city, counting the head offices of every type of investor, the largest groups are New York (82), San Francisco (67), Palo Alto (39) and Boston (34).
| City | State | Healthtech investors | Share of the 720 in the US |
|---|---|---|---|
| New York | NY | 82 | 11% |
| San Francisco | CA | 67 | 9% |
| Palo Alto | CA | 39 | 5% |
| Boston | MA | 34 | 5% |
| Menlo Park | CA | 24 | 3% |
| Austin | TX | 23 | 3% |
| Chicago | IL | 19 | 3% |
| Los Angeles | CA | 15 | 2% |
Metro area lists for this sector, each with its own row count: Healthtech investors in the San Francisco Bay Area (182), Healthtech investors in Silicon Valley (91), Healthtech investors in Los Angeles (37), Healthtech investors in Austin (23), Healthtech investors in Miami and South Florida (19).
The same investors as lists by region: Healthtech venture capital firms in the US (709), Healthtech investors in the UK (194), Healthtech investors in Europe (291).
How big are healthtech and digital health funds?
Across the 514 of the 1,207 healthtech and digital health investors with a fund size from SEC Form D on file, the median is $60M, above the $50M for every investor we hold with such a figure. About a quarter of these funds are under $25M and about two fifths are $100M or more. The figure is the fund as filed, not a check size, and a firm's main fund on our record, which is not always its newest; for 109 of the 514 the offering amount is indefinite, so it is the amount sold so far.
| Fund size on file (SEC Form D) | Healthtech investors | Share | Share, all investors with a figure |
|---|---|---|---|
| Under $10M | 54 | 11% | 15% |
| $10M to $25M | 81 | 16% | 18% |
| $25M to $50M | 65 | 13% | 15% |
| $50M to $100M | 106 | 21% | 19% |
| $100M to $250M | 118 | 23% | 19% |
| $250M to $1B | 84 | 16% | 12% |
| $1B and over | 6 | 1% | 1% |
Which healthtech and digital health investors can you look at first?
Health investors divide by what they will underwrite: software and services, regulated devices, or drugs. A digital health fund is unlikely to take clinical trial risk, and a life sciences fund is unlikely to back a scheduling app. Place yourself in one group and filter to it.
The 6 firms below are among the free rows of our list of healthtech venture capital firms in the US (709): each names the sector in its own description, and they stand in that list's order, by our activity score, which is no measure of quality.
Digitalis Ventures
HQ: New York, New York · Type: VC firm · Stages (our research): Seed · Latest activity: Portfolio news, Nov 2026 (our research) · Private fund assets: $862M (SEC Form ADV)
New York venture firm investing in biotechnology and technology-enabled healthcare for human health, and in animal health companies through its Companion Funds.
Gore Range Capital
HQ: Southlake, Texas · Type: VC firm · Stages (our research): Seed · Latest activity: New deal, Aug 2026 (our research) · Fund size on file: $250M (SEC Form D, 2026)
Healthcare investment firm founded in 2015 backing early-stage companies in precision health, regenerative medicine, personalized therapeutics and longevity.
Town Hall Ventures
HQ: New York, New York · Type: VC firm · Stages (our research): Growth · Latest activity: New deal, Sep 2026 (our research) · Fund size on file: $400M (SEC Form D, 2025)
Healthcare venture firm founded in 2018 that backs technology and service companies serving underserved populations, such as seniors, rural communities and school-based mental health. Based in New York, NY.
Narya
HQ: Columbus, Ohio · Type: VC firm · Stages (our research): Seed · Latest activity: Form D filing, Sep 2026 · Fund size on file: $200M (SEC Form D, 2026)
Columbus, OH concentrated early-stage firm backing founders in large markets such as healthcare, space and defense, advanced therapies and American manufacturing.
Frist Cressey Ventures
HQ: Nashville, Tennessee · Type: VC firm · Latest activity: New deal, Oct 2026 (our research) · Fund size on file: $400M (SEC Form D, 2025)
Venture firm focused on healthcare companies, supporting portfolio businesses beyond capital with strategic help. Based in Nashville, TN.
Health Velocity Capital
HQ: San Mateo, California · Type: VC firm · Latest activity: Form D filing, Aug 2026 · Fund size on file: $300M (SEC Form D, 2025)
San Mateo, CA firm investing exclusively in healthcare software and services companies, with capital partly from healthcare organizations and executives.
Which US healthtech and digital health investors filed with the SEC most recently?
275 of the 720 US healthtech and digital health investors (38%) have a Form D filing dated in the 12 months to 6 Nov 2026, a first notice or the yearly amendment of an older fund, in line with the 38% for all US investors we hold. Our file of new fund notices for the 8 weeks to 6 Nov 2026 holds 62 from 40 of these investors, among them Quiet Capital, Branch Venture Partners and LightX Capital.
| Investor | Location | Stages (our research) | Latest Form D filing | Amount on that filing |
|---|---|---|---|---|
| Quiet Capital | San Francisco, California | Pre-seed | 6 Nov 2026 | Not stated |
| LightX Capital | Chicago, Illinois | Pre-seed | 4 Nov 2026 | Not stated |
| Hyve Ventures | Austin, Texas | Pre-seed | 3 Nov 2026 | $6M |
| 25Madison Ventures | New York, New York | Pre-seed, Seed, Series A | 30 Oct 2026 | $50M |
| Future Ventures | Los Altos, California | Seed | 30 Oct 2026 | Not stated |
| Draper Associates | San Mateo, California | Pre-seed, Seed, Series A | 29 Oct 2026 | $40M |
| Audere | Austin, Texas | Growth | 28 Oct 2026 | Not stated |
| SJF Ventures | Durham, North Carolina | Not stated | 28 Oct 2026 | $2M |
What should a healthtech and digital health founder have ready before the first email?
A health company is asked who pays and what proves the product works, so lead with those two.
- The payer for each product line, and the price or reimbursement already agreed.
- Clinical evidence to date, with the partner and the design of the study.
- Your regulatory position: which rules apply, what is cleared and what is pending.
Words healthtech and digital health investors use
- Payer
- The party that pays for care, such as an insurer, an employer or a public program.
- Reimbursement
- Payment by an insurer or a public program for a service or a product.
- HIPAA
- The US law that sets rules for patient health information held by health plans, care providers and the companies that handle data for them.
- Clinical validation
- Evidence from a study that the product does for patients what it claims.
A common slip. Naming the patient as the customer when someone else pays. Lead with the payer and the price they have agreed to.
How do you reach healthtech and digital health investors?
91% of the list has a named decision-maker on file (1,104 of 1,207, 5,558 names in all), above the 84% across the whole database. 46% have a firm email address (558), and 371 publish how they want to be pitched, such as a form or an application page.
Use a pitch route where a firm publishes one, and otherwise write to one named person at a time, starting from the free outreach email templates; the full list is Healthtech investors, all 1,207 investors, one per row, the first 25 free to read, and the matching tool opens with healthtech and digital health already picked.
This list has 1,207 rows and a single-list file covers up to 300, so its rows are sold inside the Global Bundle file.
One-time payment. No subscription. No account.
Or get the free sample file (100 investors) first.
Method and limits
- Source
- SEC Form D for filing dates and fund sizes; our own research (each firm's website, UK and EU registers) for stage, the sector tag and dated deals.
- Counts
- The 1,207 rows of the list this page links to, as of November 2026, set against all 4,178 investors we hold (3,019 in the US); a gap under 3 points is treated as none, and a rank compares the sectors that have a list on this site and at least 30 rows for the measure (10 for a median fund size).
- Limits
- 1,302 US firms have no sector on file, so the true number of healthtech and digital health investors is higher; 1,043 of the 1,207 here have a stage on file and 514 a fund size from SEC Form D; what investors look for, which ones to keep, the words they use and what to have ready are our advice for this sector, not data about any one investor.
Questions
How do I find investors for a healthtech and digital health startup?
Start from the list of 1,207 healthtech and digital health investors, then filter by stage (800 of the 1,043 with a stage on file name seed), by place (34% of the US ones with a state on file are in California) and by fund size (the median fund on file is $60M).
What do healthtech and digital health investors ask founders?
Who pays, and how? What clinical evidence do you have? Which rules apply to you?
How big are healthtech and digital health funds?
The median fund on file is $60M across the 514 healthtech and digital health investors with a figure from SEC Form D, above the $50M for every investor we hold with such a figure.
Can I contact healthtech and digital health investors directly?
1,104 of the 1,207 have a named decision-maker on file and 558 a firm email address; 371 publish a pitch route, and where one exists it is the way in they ask for.
Guides for other sectors
How to find consumer products and CPG investorsHow to find consumer investorsHow to find ecommerce investorsHow to find edtech investorsHow to find proptech and real estate tech investorsHow to find climate tech investorsHow to find deep tech investorsHow to find hardware investorsHow to find impact investorsHow to find food and beverage investorsHow to find SaaS and B2B software investorsHow to find fintech investorsHow to find AI investorsHow to find cybersecurity investorsHow to find gaming investors
Related
Healthtech investors (1,207)Healthtech venture capital firms in the US (709)Healthtech investors in the UK (194)Healthtech investors in Europe (291)Seed healthtech investors (800)Pre-seed healthtech investors (408)Healthtech investors in California (240)Healthtech investors in New York (100)Match healthtech and digital health investors to your roundHow to build an investor listInvestor outreach email templatesHow many investors to pitchInvestor databases comparedWhat is in the investor database
Cite this page
Muhammad Tayyab Shabbir, "How to Find Investors for a Healthtech Startup: Stage Mix, States and Fund Sizes", The Investor Database, 10 Nov 2026. https://theinvestordatabase.com/guides/how-to-find-investors-for-a-healthtech-startup/